| 1 | an | 264,602 |
| 2 | sinogram-affirmed | 10 |
| 3 | als-trained | 4 |
| 4 | rar-related | 3 |
| 5 | wind-damp-heat | 3 |
| 6 | 'possibly | 2 |
| 7 | 'therapist | 2 |
| 8 | 3,004 | 2 |
| 9 | 3,586 | 2 |
| 10 | 46,208 | 2 |
| 11 | accucheck | 2 |
| 12 | demystifying | 2 |
| 13 | noncontroversial | 2 |
| 14 | pod+3 | 2 |
| 15 | state-regulated | 2 |
| 16 | stepstone | 2 |
| 17 | ultra-high-speed | 2 |
| 18 | well-referenced | 2 |
| 19 | ≥2.5-fold | 2 |
| 20 | 'describe | 1 |
| 21 | 0.89/year | 1 |
| 22 | 1.5-2.0h | 1 |
| 23 | 139,351 | 1 |
| 24 | 145/80 | 1 |
| 25 | 17alpha-20alpha-dihydroxypregn-4-en-3-one | 1 |
| 26 | 2.5-3.6-fold | 1 |
| 27 | 20-bp | 1 |
| 28 | 2000u | 1 |
| 29 | 2011/12.the | 1 |
| 30 | 24/7/365 | 1 |
| 31 | 281,750 | 1 |
| 32 | 50-minutes | 1 |
| 33 | 500-µm | 1 |
| 34 | 54,464 | 1 |
| 35 | 603bp | 1 |
| 36 | 6277 | 1 |
| 37 | 8863 | 1 |
| 38 | a1h | 1 |
| 39 | abcc-type | 1 |
| 40 | addressed-for | 1 |
| 41 | adenovirus-expressing | 1 |
| 42 | adma/arginine | 1 |
| 43 | age-the | 1 |
| 44 | alarm-prompted | 1 |
| 45 | alternating-month | 1 |
| 46 | another.• | 1 |
| 47 | anti-american | 1 |
| 48 | artificial-intelligence-based | 1 |
| 49 | asthma.an | 1 |
| 50 | as₃d | 1 |
| 51 | attitude-based | 1 |
| 52 | berlin-frankfürt-münster-derived | 1 |
| 53 | block-wide | 1 |
| 54 | brain-intestine | 1 |
| 55 | carbon-yl-carbonyl | 1 |
| 56 | caution.an | 1 |
| 57 | center-reported | 1 |
| 58 | cves.kidney | 1 |
| 59 | cyp2c19-homozygous | 1 |
| 60 | cyropreserved | 1 |
| 61 | deff | 1 |
| 62 | dex-associated | 1 |
| 63 | direct-touching | 1 |
| 64 | double-size | 1 |
| 65 | dxas | 1 |
| 66 | ecophysiologically | 1 |
| 67 | empathy-related | 1 |
| 68 | erosion-proofing | 1 |
| 69 | eugenol-free | 1 |
| 70 | event-rate/year | 1 |
| 71 | fine/gross | 1 |
| 72 | focally/diffuse | 1 |
| 73 | free-model | 1 |
| 74 | gaussian-based | 1 |
| 75 | ghe-evoked | 1 |
| 76 | gps-collared | 1 |
| 77 | heat-bath | 1 |
| 78 | high-interactive | 1 |
| 79 | hydroxy-midazolam | 1 |
| 80 | hypokalemia-an | 1 |
| 81 | ica/gadab | 1 |
| 82 | insult/nonsexually | 1 |
| 83 | integration-free | 1 |
| 84 | intrahepatic/extrahepatic | 1 |
| 85 | k2co3in | 1 |
| 86 | korea.an | 1 |
| 87 | lamprey-crh | 1 |
| 88 | laparoscopic/laparoscopic | 1 |
| 89 | measurable/assessable | 1 |
| 90 | melipona | 1 |
| 91 | mnpropo | 1 |
| 92 | motomet | 1 |
| 93 | ms.video | 1 |
| 94 | necroptosis-an | 1 |
| 95 | needlescopically | 1 |
| 96 | nef-mediated | 1 |
| 97 | nicolai | 1 |
| 98 | non-relationship-based | 1 |
| 99 | non-stent-based | 1 |
| 100 | normal/below | 1 |
| 101 | oa-gcmaf-based | 1 |
| 102 | odorant-guided | 1 |
| 103 | oihd.one | 1 |
| 104 | opposing/competing | 1 |
| 105 | parents.an | 1 |
| 106 | penalty-free | 1 |
| 107 | pge2-provoked | 1 |
| 108 | physiotherapist-provided | 1 |
| 109 | plastoglobules | 1 |
| 110 | post-validation | 1 |
| 111 | pre-1991 | 1 |
| 112 | pro-ana | 1 |
| 113 | raf-inhibitor-resistant | 1 |
| 114 | relativistically | 1 |
| 115 | repetitve | 1 |
| 116 | responsivities | 1 |
| 117 | reticlocyte | 1 |
| 118 | risperidone-associated | 1 |
| 119 | rvsp/sbp | 1 |
| 120 | shrout-fleiss | 1 |
| 121 | slc6a4/5htt | 1 |
| 122 | slow-light | 1 |
| 123 | spottings | 1 |
| 124 | success-associated | 1 |
| 125 | suggested-with | 1 |
| 126 | suitabley | 1 |
| 127 | supraventricular-ventricular | 1 |
| 128 | suture.an | 1 |
| 129 | taken.the | 1 |
| 130 | time-reversible | 1 |
| 131 | tonotopically | 1 |
| 132 | tri-directional | 1 |
| 133 | unremarkably | 1 |
| 134 | voic | 1 |
| 135 | yohimbine-associated | 1 |
| 136 | αs1-casein | 1 |
| 137 | β-cell-directed | 1 |
| 1 | 'describe | 1 |
| 2 | 'possibly | 2 |
| 3 | 'therapist | 2 |
| 4 | 0.89/year | 1 |
| 5 | 1.5-2.0h | 1 |
| 6 | 139,351 | 1 |
| 7 | 145/80 | 1 |
| 8 | 17alpha-20alpha-dihydroxypregn-4-en-3-one | 1 |
| 9 | 2.5-3.6-fold | 1 |
| 10 | 20-bp | 1 |
| 11 | 2000u | 1 |
| 12 | 2011/12.the | 1 |
| 13 | 24/7/365 | 1 |
| 14 | 281,750 | 1 |
| 15 | 3,004 | 2 |
| 16 | 3,586 | 2 |
| 17 | 46,208 | 2 |
| 18 | 50-minutes | 1 |
| 19 | 500-µm | 1 |
| 20 | 54,464 | 1 |
| 21 | 603bp | 1 |
| 22 | 6277 | 1 |
| 23 | 8863 | 1 |
| 24 | a1h | 1 |
| 25 | abcc-type | 1 |
| 26 | accucheck | 2 |
| 27 | addressed-for | 1 |
| 28 | adenovirus-expressing | 1 |
| 29 | adma/arginine | 1 |
| 30 | age-the | 1 |
| 31 | alarm-prompted | 1 |
| 32 | als-trained | 4 |
| 33 | alternating-month | 1 |
| 34 | an | 264,602 |
| 35 | another.• | 1 |
| 36 | anti-american | 1 |
| 37 | artificial-intelligence-based | 1 |
| 38 | asthma.an | 1 |
| 39 | as₃d | 1 |
| 40 | attitude-based | 1 |
| 41 | berlin-frankfürt-münster-derived | 1 |
| 42 | block-wide | 1 |
| 43 | brain-intestine | 1 |
| 44 | carbon-yl-carbonyl | 1 |
| 45 | caution.an | 1 |
| 46 | center-reported | 1 |
| 47 | cves.kidney | 1 |
| 48 | cyp2c19-homozygous | 1 |
| 49 | cyropreserved | 1 |
| 50 | deff | 1 |
| 51 | demystifying | 2 |
| 52 | dex-associated | 1 |
| 53 | direct-touching | 1 |
| 54 | double-size | 1 |
| 55 | dxas | 1 |
| 56 | ecophysiologically | 1 |
| 57 | empathy-related | 1 |
| 58 | erosion-proofing | 1 |
| 59 | eugenol-free | 1 |
| 60 | event-rate/year | 1 |
| 61 | fine/gross | 1 |
| 62 | focally/diffuse | 1 |
| 63 | free-model | 1 |
| 64 | gaussian-based | 1 |
| 65 | ghe-evoked | 1 |
| 66 | gps-collared | 1 |
| 67 | heat-bath | 1 |
| 68 | high-interactive | 1 |
| 69 | hydroxy-midazolam | 1 |
| 70 | hypokalemia-an | 1 |
| 71 | ica/gadab | 1 |
| 72 | insult/nonsexually | 1 |
| 73 | integration-free | 1 |
| 74 | intrahepatic/extrahepatic | 1 |
| 75 | k2co3in | 1 |
| 76 | korea.an | 1 |
| 77 | lamprey-crh | 1 |
| 78 | laparoscopic/laparoscopic | 1 |
| 79 | measurable/assessable | 1 |
| 80 | melipona | 1 |
| 81 | mnpropo | 1 |
| 82 | motomet | 1 |
| 83 | ms.video | 1 |
| 84 | necroptosis-an | 1 |
| 85 | needlescopically | 1 |
| 86 | nef-mediated | 1 |
| 87 | nicolai | 1 |
| 88 | non-relationship-based | 1 |
| 89 | non-stent-based | 1 |
| 90 | noncontroversial | 2 |
| 91 | normal/below | 1 |
| 92 | oa-gcmaf-based | 1 |
| 93 | odorant-guided | 1 |
| 94 | oihd.one | 1 |
| 95 | opposing/competing | 1 |
| 96 | parents.an | 1 |
| 97 | penalty-free | 1 |
| 98 | pge2-provoked | 1 |
| 99 | physiotherapist-provided | 1 |
| 100 | plastoglobules | 1 |
| 101 | pod+3 | 2 |
| 102 | post-validation | 1 |
| 103 | pre-1991 | 1 |
| 104 | pro-ana | 1 |
| 105 | raf-inhibitor-resistant | 1 |
| 106 | rar-related | 3 |
| 107 | relativistically | 1 |
| 108 | repetitve | 1 |
| 109 | responsivities | 1 |
| 110 | reticlocyte | 1 |
| 111 | risperidone-associated | 1 |
| 112 | rvsp/sbp | 1 |
| 113 | shrout-fleiss | 1 |
| 114 | sinogram-affirmed | 10 |
| 115 | slc6a4/5htt | 1 |
| 116 | slow-light | 1 |
| 117 | spottings | 1 |
| 118 | state-regulated | 2 |
| 119 | stepstone | 2 |
| 120 | success-associated | 1 |
| 121 | suggested-with | 1 |
| 122 | suitabley | 1 |
| 123 | supraventricular-ventricular | 1 |
| 124 | suture.an | 1 |
| 125 | taken.the | 1 |
| 126 | time-reversible | 1 |
| 127 | tonotopically | 1 |
| 128 | tri-directional | 1 |
| 129 | ultra-high-speed | 2 |
| 130 | unremarkably | 1 |
| 131 | voic | 1 |
| 132 | well-referenced | 2 |
| 133 | wind-damp-heat | 3 |
| 134 | yohimbine-associated | 1 |
| 135 | αs1-casein | 1 |
| 136 | β-cell-directed | 1 |
| 137 | ≥2.5-fold | 2 |
| 1 | 281,750 | 1 |
| 2 | 145/80 | 1 |
| 3 | 139,351 | 1 |
| 4 | pre-1991 | 1 |
| 5 | pod+3 | 2 |
| 6 | 8863 | 1 |
| 7 | 3,004 | 2 |
| 8 | 54,464 | 1 |
| 9 | 24/7/365 | 1 |
| 10 | 3,586 | 2 |
| 11 | 6277 | 1 |
| 12 | 46,208 | 2 |
| 13 | pro-ana | 1 |
| 14 | melipona | 1 |
| 15 | ica/gadab | 1 |
| 16 | voic | 1 |
| 17 | laparoscopic/laparoscopic | 1 |
| 18 | intrahepatic/extrahepatic | 1 |
| 19 | well-referenced | 2 |
| 20 | odorant-guided | 1 |
| 21 | physiotherapist-provided | 1 |
| 22 | ultra-high-speed | 2 |
| 23 | ghe-evoked | 1 |
| 24 | pge2-provoked | 1 |
| 25 | sinogram-affirmed | 10 |
| 26 | als-trained | 4 |
| 27 | gps-collared | 1 |
| 28 | artificial-intelligence-based | 1 |
| 29 | attitude-based | 1 |
| 30 | oa-gcmaf-based | 1 |
| 31 | gaussian-based | 1 |
| 32 | non-relationship-based | 1 |
| 33 | non-stent-based | 1 |
| 34 | yohimbine-associated | 1 |
| 35 | risperidone-associated | 1 |
| 36 | success-associated | 1 |
| 37 | dex-associated | 1 |
| 38 | nef-mediated | 1 |
| 39 | rar-related | 3 |
| 40 | empathy-related | 1 |
| 41 | state-regulated | 2 |
| 42 | β-cell-directed | 1 |
| 43 | alarm-prompted | 1 |
| 44 | center-reported | 1 |
| 45 | berlin-frankfürt-münster-derived | 1 |
| 46 | cyropreserved | 1 |
| 47 | ≥2.5-fold | 2 |
| 48 | 2.5-3.6-fold | 1 |
| 49 | as₃d | 1 |
| 50 | 'describe | 1 |
| 51 | block-wide | 1 |
| 52 | eugenol-free | 1 |
| 53 | integration-free | 1 |
| 54 | penalty-free | 1 |
| 55 | age-the | 1 |
| 56 | 2011/12.the | 1 |
| 57 | taken.the | 1 |
| 58 | measurable/assessable | 1 |
| 59 | time-reversible | 1 |
| 60 | adma/arginine | 1 |
| 61 | brain-intestine | 1 |
| 62 | 17alpha-20alpha-dihydroxypregn-4-en-3-one | 1 |
| 63 | oihd.one | 1 |
| 64 | stepstone | 2 |
| 65 | abcc-type | 1 |
| 66 | focally/diffuse | 1 |
| 67 | reticlocyte | 1 |
| 68 | high-interactive | 1 |
| 69 | repetitve | 1 |
| 70 | double-size | 1 |
| 71 | deff | 1 |
| 72 | erosion-proofing | 1 |
| 73 | direct-touching | 1 |
| 74 | adenovirus-expressing | 1 |
| 75 | opposing/competing | 1 |
| 76 | demystifying | 2 |
| 77 | 1.5-2.0h | 1 |
| 78 | a1h | 1 |
| 79 | lamprey-crh | 1 |
| 80 | heat-bath | 1 |
| 81 | suggested-with | 1 |
| 82 | alternating-month | 1 |
| 83 | nicolai | 1 |
| 84 | accucheck | 2 |
| 85 | noncontroversial | 2 |
| 86 | tri-directional | 1 |
| 87 | free-model | 1 |
| 88 | carbon-yl-carbonyl | 1 |
| 89 | hydroxy-midazolam | 1 |
| 90 | 500-µm | 1 |
| 91 | an | 264,602 |
| 92 | hypokalemia-an | 1 |
| 93 | necroptosis-an | 1 |
| 94 | korea.an | 1 |
| 95 | asthma.an | 1 |
| 96 | suture.an | 1 |
| 97 | caution.an | 1 |
| 98 | parents.an | 1 |
| 99 | anti-american | 1 |
| 100 | k2co3in | 1 |
| 101 | αs1-casein | 1 |
| 102 | post-validation | 1 |
| 103 | ms.video | 1 |
| 104 | mnpropo | 1 |
| 105 | 20-bp | 1 |
| 106 | 603bp | 1 |
| 107 | rvsp/sbp | 1 |
| 108 | 0.89/year | 1 |
| 109 | event-rate/year | 1 |
| 110 | supraventricular-ventricular | 1 |
| 111 | addressed-for | 1 |
| 112 | dxas | 1 |
| 113 | responsivities | 1 |
| 114 | plastoglobules | 1 |
| 115 | 50-minutes | 1 |
| 116 | spottings | 1 |
| 117 | shrout-fleiss | 1 |
| 118 | fine/gross | 1 |
| 119 | cyp2c19-homozygous | 1 |
| 120 | wind-damp-heat | 3 |
| 121 | motomet | 1 |
| 122 | slow-light | 1 |
| 123 | raf-inhibitor-resistant | 1 |
| 124 | 'therapist | 2 |
| 125 | slc6a4/5htt | 1 |
| 126 | 2000u | 1 |
| 127 | normal/below | 1 |
| 128 | suitabley | 1 |
| 129 | cves.kidney | 1 |
| 130 | unremarkably | 1 |
| 131 | 'possibly | 2 |
| 132 | ecophysiologically | 1 |
| 133 | needlescopically | 1 |
| 134 | tonotopically | 1 |
| 135 | relativistically | 1 |
| 136 | insult/nonsexually | 1 |
| 137 | another.• | 1 |